Quantum Computing in Healthcare - Global Strategic Business Report

The global market for Quantum Computing in Healthcare was valued at US$128.5 Million in 2024 and is projected to reach US$845.4 Million by 2030, growing at a CAGR of 36.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Quantum Computing in Healthcare market.

Global Quantum Computing in Healthcare Market - Key Trends & Drivers Summarized

Exploring Its Game-Changing Potential in Healthcare

Quantum computing is poised to revolutionize healthcare by unlocking levels of computational power far beyond what classical computers can achieve. At its core, quantum computing leverages the principles of superposition and entanglement to process complex datasets simultaneously - making it uniquely suited for the multifaceted and data-intensive challenges of modern medicine. The global healthcare sector is increasingly exploring quantum computing to address areas such as drug discovery, genomics, personalized medicine, disease modeling, and medical imaging. While still in the early stages of practical deployment, rapid advancements in quantum hardware and algorithms are propelling this market toward real-world applications that could transform clinical outcomes and operational efficiencies.

Key market trends include the emergence of hybrid quantum-classical systems designed to accelerate biomedical simulations and molecular modeling. These systems enable researchers to analyze vast molecular interactions and protein folding processes more efficiently than ever before, significantly cutting down the time required for drug development and clinical trials. Another notable trend is the increasing collaboration between quantum technology providers and pharmaceutical, biotech, and research institutions. These partnerships aim to co-develop quantum-based platforms for biomarker discovery, compound screening, and treatment optimization. As cloud-accessible quantum environments become more widespread, healthcare organizations of all sizes are gaining entry to this transformative capability without the need for specialized quantum infrastructure.

How Is Quantum Computing Reshaping Drug Discovery and Disease Modeling?

Drug discovery is one of the most promising frontiers for quantum computing in healthcare. Traditional computational models often struggle with simulating molecular interactions at the atomic level due to the sheer number of variables and combinations involved. Quantum computers, with their ability to process multiple possibilities simultaneously, offer a fundamentally new way to approach molecular simulation. This makes it feasible to predict the binding affinity between drugs and their target proteins with high accuracy, paving the way for the development of more effective therapies at a fraction of the time and cost. Quantum algorithms are also being explored for de novo drug design, where entirely new compounds can be generated and optimized based on desired biological properties.

Beyond drug development, quantum computing holds promise for more accurate disease modeling and predictive analytics. Complex diseases like cancer, Alzheimer’s, and autoimmune disorders involve numerous genetic, environmental, and behavioral factors. Quantum systems can process these interdependencies more holistically, allowing researchers to build highly detailed simulations of disease progression and response to treatment. In epidemiology and public health, quantum-powered models are being used to simulate outbreak scenarios and healthcare resource allocation strategies, improving preparedness for pandemics and large-scale health events. These capabilities could vastly enhance the healthcare sector’s ability to understand, prevent, and treat complex illnesses with unprecedented precision.

Where Is Quantum Computing Gaining Traction in Diagnostics and Personalization?

Quantum computing is also beginning to make its mark in the areas of diagnostics and personalized medicine, where the ability to process and interpret massive and heterogeneous datasets is crucial. Genomics, in particular, stands to benefit immensely. Analyzing the human genome involves examining billions of base pairs and identifying patterns that correlate with diseases, traits, or drug responses. Quantum algorithms can accelerate this analysis, enabling faster and more accurate identification of genetic mutations and biomarkers. This supports the development of tailored treatment plans based on a patient’s unique genetic makeup, improving outcomes and minimizing adverse reactions.

Medical imaging and diagnostics are also seeing early applications of quantum-enhanced machine learning. Quantum algorithms are being tested for improving image reconstruction and classification tasks in radiology, pathology, and cardiology. These systems can process and learn from large imaging datasets with greater speed and accuracy, potentially enabling earlier and more precise diagnoses. In clinical decision support systems, quantum computing is being explored to combine real-time patient data with historical clinical outcomes to recommend optimal treatment pathways. As healthcare providers seek to implement more data-driven and patient-centric care models, quantum-enabled tools are expected to play an increasingly strategic role.

What’s Fueling the Growth in the Quantum Computing in Healthcare Market?

The growth in the quantum computing in healthcare market is driven by several factors rooted in technological progress, rising healthcare data complexity, and increased investment in precision medicine. One of the primary drivers is the need for faster and more accurate drug discovery tools. The traditional R&D pipeline is costly and time-intensive, and quantum systems offer a path to streamline compound screening, molecular simulation, and clinical trial design. Secondly, the explosion of genomic and biomedical data - alongside advances in bioinformatics - has created a demand for high-powered computing platforms that can handle multilayered datasets with speed and granularity.

The increasing application of AI and machine learning in healthcare is also propelling demand for quantum-enhanced algorithms that can improve predictive accuracy and reduce training times for large models. Partnerships between quantum hardware developers and life sciences companies are accelerating innovation and bringing pilot projects into real-world testing. Moreover, the emergence of cloud-based quantum computing platforms is democratizing access to quantum tools, allowing research institutions, hospitals, and biotech firms to experiment without the capital-intensive burden of quantum infrastructure. Additionally, the growing focus on personalized medicine - driven by genomics, digital health records, and wearable technologies - is creating new use cases that require the multidimensional data processing power that only quantum computing can deliver. Collectively, these forces are not only driving adoption but positioning quantum computing as a foundational technology for the next era of advanced, data-driven healthcare.

Report Scope

The report analyzes the Quantum Computing in Healthcare market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Component (Services, Software, Hardware); Technology (Superconducting Qubits, Trapped Ions, Quantum Annealing, Other Technologies); End-User (Pharma & Biopharma Companies, Laboratories & Research Institutes, Healthcare Providers, Healthcare Payers).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Services segment, which is expected to reach US$452.4 Million by 2030 with a CAGR of a 40.1%. The Software segment is also set to grow at 36.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $36.2 Million in 2024, and China, forecasted to grow at an impressive 34.0% CAGR to reach $116.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Quantum Computing in Healthcare Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Quantum Computing in Healthcare Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Quantum Computing in Healthcare Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Classiq, D-Wave Systems Inc., ID Quantique SA, ProteinQure, Inc., Protiviti Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 23 companies featured in this Quantum Computing in Healthcare market report include:

• Classiq
• D-Wave Systems Inc.
• ID Quantique SA
• ProteinQure, Inc.
• Protiviti Inc.
• QC Ware Corp.
• Qnami AB
• Quantinuum
• Rigetti Computing
• Zapata Computing

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry